The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its ...
Smithsonian Magazine on MSN21h
FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab RatsThe synthetic additive found in thousands of food products will now be phased out by 2027, but advocates say the agency's ...
Verywell Health on MSN20h
Pristiq vs. Effexor: How Do They Compare?Pristiq (desvenlafaxine) and Effexor (venlafaxine) are SNRIs. Pristiq treats depression, while Effexor treats depression and ...
The Food and Drug Administration is facing some backlash from hedge fund manager Bill Ackman about how long it took to ban Red No. 3 from the U.S. supply chain.
In the face of an opioid overdose crisis, President Biden oversaw a historic shift toward harm reduction for addiction.
Newsweek spoke to experts about the FDA's suggestion to place nutrition information on the front of packaged foods.
The FDA has granted Fast Track designation to SPG601 for the treatment of Fragile X syndrome, a common inherited cause of autism.
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The Manila Times on MSN21h
FDA set to reduce drug registration timelineTHE Food and Drug Administration (FDA) said Friday that it is set to release a new administrative order that would reduce the timeline of drug registration, especially among imported drugs that have ...
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
The case of the Canadian teen and the death of a Louisiana man are stark reminders of bird flu’s capacity to ignite serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback